Concepedia
Publication | Open Access
T Cells Redirected to EphA2 for the Immunotherapy of Glioblastoma
241
Citations
38
References
2012
Year
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Roger Stupp, Warren Mason, Martin J. van den Bent, +16
New England Journal of Medicine
2005
21K
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp, Monika E. Hegi, Warren Mason, +21
The Lancet Oncology
5-Year AnalysisNeuro-oncologyOncologyRadiation TherapyAdjuvant Temozolomide +6
2009
7.7K
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao, Qiulian Wu, Roger E. McLendon, +6
Nature
Genome InstabilityRadiation TherapyMedicineRadiation EffectGlioma Stem Cells +10
2006
6.3K
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter, Bruce L. Levine, Michael Kalos, +2
Chimeric Antigen ReceptorChronic Lymphoid LeukemiaAutoimmune DiseaseLymphocyte DevelopmentImmunology +11
2011
3.5K
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan, James C. Yang, Mio Kitano, +3
Molecular Therapy
2010
2.5K
Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors.
Zelig Eshhar, Tova Waks, G. Gross, +1
Proceedings of the National Academy of Sciences
Chimeric GenesImmunologyImmunodominanceImmunologic MechanismAntigen Processing +15
1993
1.6K
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
Martin Pulé, Barbara Savoldo, Gary D. Myers, +13
Nature Medicine
Cancer ImmunosurveillanceAntitumor ActivityVirus-specific T CellsT-regulatory CellImmunology +7
2008
1.2K
Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
John H. Sampson, Amy B. Heimberger, Gary E. Archer, +13
Journal of Clinical Oncology
793
Stem Cell–Related “Self-Renewal” Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in Glioblastoma
Anastasia Murat, Eugenia Migliavacca, Thierry Gorlia, +17
728
Induction of CD8<sup>+</sup>T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
Hideho Okada, Paweł Kaliński, Ryo Ueda, +17
557
Page 1